Preferred Name | Bupivacaine | |
Synonyms |
|
|
Definitions |
An amide-type, long-acting local anesthetic. Bupivicaine reversibly binds to specific sodium ion channels in the neuronal membrane, resulting in a decrease in the voltage-dependent membrane permeability to sodium ions and membrane stabilization; inhibition of depolarization and nerve impulse conduction; and a reversible loss of sensation. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C62011 |
|
ALT_DEFINITION |
A drug used to relieve pain by blocking signals at nerve endings. It is being studied in the relief of pain following surgery for cancer. It is a type of local anesthetic. |
|
CAS_Registry |
2180-92-9 38396-39-3 |
|
CHEBI_ID |
CHEBI:3215 |
|
Chemical_Formula |
C18H28N2O |
|
code |
C62011 |
|
Contributing_Source |
CTRP FDA |
|
definition |
An amide-type, long-acting local anesthetic. Bupivicaine reversibly binds to specific sodium ion channels in the neuronal membrane, resulting in a decrease in the voltage-dependent membrane permeability to sodium ions and membrane stabilization; inhibition of depolarization and nerve impulse conduction; and a reversible loss of sensation. |
|
Display_Name |
Bupivacaine |
|
FDA_UNII_Code |
Y8335394RO |
|
Has_Salt_Form | ||
in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 |
|
label |
Bupivacaine |
|
Legacy Concept Name |
Bupivacaine_Base |
|
Preferred_Name |
Bupivacaine |
|
prefixIRI |
NCIT:C62011 |
|
prefLabel |
Bupivacaine |
|
Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
UMLS_CUI |
C0006400 |
|
subClassOf |